Is the mineralocorticoid receptor in Brown Norway rats constitutively active?

Journal of Neuroendocrinology

Volumn 12, Issue 6, 2000, Pages 576-588

  Marissal Arvy, N ^a   Ribot, E ^a   Sarrieau, ^a   Mormede ^a  

^a INSERM   (France)

Author keywords

Body weight; Brown Norway; Constitutive activation; Elevated plus maze; Fischer 344; Fluid intake; Food intake; Glucocorticoid receptor; Mineralocorticoid receptor; Plasma transcortin; Rat strains; Steroid efficiency; Thymus

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; BRAIN RECEPTOR; DEOXYCORTICOSTERONE; MINERALOCORTICOID RECEPTOR; TRANSCORTIN;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FLUID INTAKE; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; LOCOMOTION; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR DENSITY;

ADRENALECTOMY; ANDROSTANOLS; ANIMALS; BODY WEIGHT; DESOXYCORTICOSTERONE; DRINKING; EATING; HIPPOCAMPUS; LIGANDS; MALE; MAZE LEARNING; ORGAN SIZE; PITUITARY GLAND; RATS; RATS, INBRED BN; RATS, INBRED F344; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; THYMUS GLAND; TRANSCORTIN;

EID: 0034108395     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00502.x     Document Type: Article

References (68)

1. 3H]-RU 28362. Neurosci Lett 1988; 92: 14-20.
2. McEwen BS, De Kloet ER, Rostène W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66: 1121-1188.
3. Reul JMHM, Van Der Bosch FR, De Kloet ER. Relative occupation of type I and type II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol 1987; 115: 459-467.
4. Narayfejestoth A, Colombowala IK, Fejestoth G. The role of II beta-hydroxysteroid dehydrogenase in steroid hormone specificity. J Steroid Biochem Mol Biol 1998; 65: 311-316.
5. De Kloet ER, Wallach G, McEwen BS. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975; 96: 598-609.
6. Dallman MF, Akana SF. Levin N, Walker C-D, Bradbury MJ, Suemaru S, Scribner KS. Corticosteroids and the control of function in the hypothalamic-pituitary-adrenal (HPA) axis. Ann NY Acad Sci 1994; 746: 22-33.
7. De Kloet ER, Reul JMHM. Feedback action and tonic influence of Corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987; 12: 83-105.
8. Bradbury MJ, Akana SF, Dallman MF. Roles of type I and II cortico-steroid receptors in regulation of basal activity in the hypothalamic-pituitary-adrenal axis during the diurnal trough and the peak: evidence of a nonadditive effect of combined receptor occupation. Endocrinology 1994; 134: 1286-1296.
9. Schmidt TJ, Meyer AS. Autoregulation of corticosteroid receptors. How, when, where, and why? Receptor 1994; 4: 229-257.
10. File SE. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary adrenal axis. Pharmacol Ther 1990; 46: 357-375.
11. Tempel DL, Leibowitz SF. Adrenal steroid receptors: interaction with brain neuropeptide systems in relation to nutrient intake and metabolism. Neuroendocrinology 1994; 6: 479-501.
12. McEwen BS, Lambdin LT, Rainbow TC, De Nicola AF. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology 1986; 43: 38-43.
13. Verrey F. Transcriptional control of sodium transport in tight epithelia by adrenal steroids. J Memb Biol 1995; 144: 93-110.
14. Castanon N, Mormède P. Psychobiogenetics: adapted tools for the study of the coupling between behavioral and neuroendocrinc traits of emotional reactivity. Psychoneuroendocrinology 1994: 19: 257-282.
15. Sarrieau A, Mormède P. Hypothalamic pituitary adrenal axis activity in the inbred Brown Norway and Fischer 344 rat strains. Life Sci 1998; 62: 1417-1425.
16. Marissal-Arvy N, Mormède P, Sarrieau A. Strain differences in corticosteroid receptor efficiencies and regulation in Brown Norway and Fischer 344 rats. J Neuroendocrinol 1998; 11: 267-273.
17. Funder JW, Feldman D, Edelman IS. The roles of plasma binding and receptor specificity in the mineralocortieoid action of aldosterone. Endocrinology 1973; 92: 994-1004.
18. Philibert D, Moguilevsky M. RU 28362 a useful tool for the characterization of glucocorticoid and mineralocorticoid receptors. Sixty-Fifth Annual Meeting of the Endocrine Society, San Antonio. Texas, USA. 1983: 335.
19. Devenport L, Knehans A, Sundstrom A, Thomas T. Corticosterone's dual metabolic actions. Life Sci 1989; 45: 1389-1396.
20. + transport across rat inner medullary collecting duct by glucocorticoid and by mineralocorticoid hormones, J Clin Invest 1990; 86: 498-506.
21. Korte SM, De Boer SF, De Kloet ER, Bonus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995; 20: 385-394.
22. Andreatini R, Leite JR. Evidence against the involvement of ACTH/CRF release or corticosteroid receptors in the anxiolytic effect of corticosterone. Braz J Med Biol Res 1994; 27: 1237-1241.
23. File SE, Vellucci SV, Wendlandt S. Corticosterone - an anxiogenic or an anxiolytic agent ? J Pharm Pharmacol 1979; 31: 300-305.
24. Young EA, Kwak SP, Kottak J. Negative feedback regulation following administration of chronic exogenous corticosterone. J Neuroendocrinol 1995; 7: 37-45.
25. Smith CL, Hammond GL. Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat. Endocrinology 1992; 130: 2245-2251.
26. Ramos A, Berton O, Mormède P, Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 1997; 85: 57-69.
27. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167.
28. McEwcn BS, Wallach G, Magnus C. Corticosterone binding to hippocampus immediate and delayed influences of the absence of adrenal secretion. Brain Res 1974; 70: 321-334.
29. Sarrieau A, Sharma S, Meaney MJ. Postnatal development and environmental regulation of hippocampal glucocorticoid and mineralocorticoid receptors. Dev Brain Res 1988; 43: 158-162.
30. Westphal U. Steroid protein interactions. Monogr Endocrinol 1971; 4: 1-567.
31. Siiteri PK, Murai JT, Flammond GL, Nisker JF, Raymoure WJ, Kuhn RW. The serum transport of steroid hormones. Recent Prag Horm Res 1982; 38: 457-510.
32. Bradford MM. A rapid and sensitive method for the quantilation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
33. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-672.
34. Santana P, Akana SF, Hanson ES, Strack AM, Sebastian RJ, Dallman MF. Aldosterone and Dexamethasone both stimulate energy acquisition whereas only the glucocorticoid alters energy storage. Endocrinology 1995; 139: 2214-2222.
35. Hanson ES, Akana SF, Strack AM, Horsley CJ, Santana P, Dallman MF. Food intake after an overnight fast is not affected by acute alterations in corticosterone but is decreased by chronic adrenalcctomy. Stress 1996; 1: 83-93.
36. 1A receptor subtype activation in rat brain. Psychoneuroendocrinology 1993; 18: 123-130.
37. De Kloet ER, Rots NY, Van Den Berg DTWM, Oitzl MS. Brain mineralocorticoid receptor function. Ann NY Acad Sci 1994; 746: 8-21.
38. Fregly MJ, Waters IW. Effect of mineralocorticoids on spontaneous sodium chloride appetite of ADX rats. Physiol Behav 1966; 1: 65-74.
39. Naray-Fejes Toth A, Fejes Toth G. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol 1990; 259: F672-F678.
40. Hammond GL, Smith CL, Lahteenmaki P, Grolla A, Warmels-Rodenhiser S, Hodgert H, Murai JT. Siiteri PK. Squirrel monkey corticosteroid-binding globulin: primary structure and comparison with the human protein. Endocrinology 1994; 134: 891-898.
41. Andreatini R, Leite JR. The effect of corticosterone in rats submitted to the elevated plus-maze and to pentylenetetrazol-induced convulsions. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 1333-1347
42. De Kloet ER, Vreugdenhil E, Oitzl MS. Joëls M. Brain corticosteroid balance in health and disease. Endocrine Rev 1998; 19: 269-301.
43. Joëls M, Hesen W, De Kloet ER. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CAl neurons. J Neurosci 1991; 11: 2288-2294.
44. Gorman AL, Dunn AJ. Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 1993; 45: 1-7.
45. Reul JM, Probst JC, Skietella T, Hirschmann M. Stec IS, Montkowski A. Landgraf R, Holsboer F. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. Nueroendocrinology 1997; 65: 189-199.
46. Smythe JW, Murphy D, Timothy C, Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol Biochem Behav 1997; 56: 507-513.
47. Bitran D, Shiekh M, Dowd JA, Dugan MM, Renda P. Corticosterone is permissive to the anxiolytic effect that results from the blocade of hippocampal mineratocorticoid receptors. Pharmacol Biochem Behav 1998; 60: 879-887.
48. 2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Pxychoneuroendocrinology 1997; 22: 477-491.
49. Sandi C, Venero C, Guaza C. Novelty-related rapid locomotor effects of corticosterone in rats. Eur J Neurosci 1996; 8: 794-800.
50. Breuner CW, Greenberg AL, Wingfield JC. Noninvasive corticosterone treatment rapidly increases activity in Gambel's white crowned sparrows. Gen Comp Endocrinol 1998; 111: 386-394.
51. Oitzl MR, Fluttert M, De Kloet ER. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticoid receptors. Eur J Neurosci 1994; 6: 1072-1079.
52. Spencer RL, Miller AH, Stein M, McEwen BS. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res 1991; 549: 236-246.
53. De Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991; 12: 95-164.
54. Sapolsky RM, Stein-Behrens BA, Armanini MP. Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus. Exp Neurol 1991; 114: 246-249.
55. Sloviter RS, Valiquette G, Abrams GM, Ronk EC, Sollas AL, Paul LA, Neubort S. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 1989; 243: 535-538.
56. Ahima RS, Harlan RE. Differential corticosteroid regulation of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system: topography and implications. Endocrinology 1991; 129: 226-236.
57. Dubois DC, Xu Z-X, McKay L, Almon RR, Pyszcznski N, Jusko WJ. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment. J Steroid Biochem Molec Biol 1995; 54: 237-243.
58. Jacobson L, Akana SF, Cascio CS, Scribner K, Shinsako J, Dallman MF. The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress. Endocrinology 1989; 124: 2144-2152.
59. Buckingham JC, Hodges JR. Interrelationships of pituitary and plasma corticotrophin and plasma corticosterone in adrenalectomized and stressed, adrenalectomized rats. J Endocr 1974; 63: 231-222.
60. Koch B. Lutz-Bucher B, Briaud B, Mialhe C. Relationship between ACTH secretion and corticoid binding to specific receptors in perifused adenohypophyses. Neuroendocrinology 1979; 28: 167-177.
61. Rappay G, Makara GB. A quantitative approach to trace the corticotrophs in culture after adrenalectomy. Histochemistry 1981;73: 131-136.
62. Gertz BJ, Contreras LN, McComb DJ, Kovacs K, Tyrrell JB, Dallman MF. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 1987; 120: 381-388.
63. Gulyas M, Pusztai L. Rappay G, Makara GB. Pituitary corticotrophs proliferate temporarily after adrenalectomy. Histochemistry 1991; 96: 185-189.
64. Childs GV, Rougeau D, Unabia G. Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes. Endocrinology 1995; 136: 1595-1602.
65. Herman JP, Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J Neurosci 1998; 18: 7462-7473.
66. Hu Z, Yurl K, Morimoto M, Ozawa H, Kawata M. Chronic loss of glucocorticoids following adrenalectomy down-regulates the expression of glucocorticoid receptor mRNA in the rat forebrain. Eur J Neurosci 1997; 9: 1778-1783.
67. Cramer S, Ebert U, Löscher W. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: comparison of inbred strains. Epilepsia 1998; 39: 1046-1053.
68. Shimkets RA, Lifton RP. Recent advances in the molecular genetics of hypertension. Curr Opin Nephrol Hypertens 1996; 5: 162-165.